Tafluprost Solution/ Drops
Product Images NDC 42571-264

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tafluprost (NDC 42571-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tafluprost-ampule.jpg (Tafluprost Ampule)

Label showing Tafluprost Ophthalmic Solution with a concentration of 0.0015%. The label states it is for use in the eye, made in India, and is available by prescription only. The label also includes an artwork code.*

FDA Label Image

Tafluprost-carton.jpg (Tafluprost Carton)

Tafluprost Ophthalmic Solution 0.0015% in single-dose containers for topical eye application. The packaging displays 15 single-dose containers, each containing 0.3 mL. It is labeled as prescription only, preservative-free, sterile, and requires refrigeration between 2° to 8°C (36° to 46°F). Manufactured by Micro Labs Limited, India, and marketed by Micro Labs USA, Inc.*

FDA Label Image

Tafluprost-figure1.jpg (Tafluprost Figure1)

An illustration showing a hand holding an ophthalmic dropper bottle, with the dropper tip positioned upwards, likely demonstrating how to hold the eye drop container before use.*

FDA Label Image

Tafluprost-figure2.jpg (Tafluprost Figure2)

An instructional illustration showing hands opening a single-dose container of tafluprost ophthalmic solution. The image demonstrates twisting and pulling the container cap to access the solution dropper for ophthalmic use.*

FDA Label Image

Tafluprost-figure3.jpg (Tafluprost Figure3)

An instructional illustration showing a person administering ophthalmic solution eye drops. The person is lying down with their head tilted back and a dropper held above the open eye to apply a single drop. This indicates usage guidance for ophthalmic solutions like tafluprost drops.*

FDA Label Image

Tafluprost-figure4.jpg (Tafluprost Figure4)

An instructional illustration showing a person administering ophthalmic drops. The individual is tilting their head back and using one hand to hold the eye open while the other hand holds a dropper bottle above the eye to apply a drop. This depicts the proper method for applying eye drops, such as tafluprost ophthalmic solution.*

FDA Label Image

Tafluprost-pouch.jpg (Tafluprost Pouch)

Drug facts text panel for Tafluprost Ophthalmic Solution 0.0015%, a preservative-free sterile solution for topical eye use. Contains 15 single-dose 0.3 mL containers. Includes storage instructions, active and inactive ingredients, dosage directions, and manufacturer details (Micro Labs Limited, India) and distributor (Micro Labs USA, Inc., NJ).*

FDA Label Image

Tafluprost-str.jpg (Tafluprost Str)

Chemical structure of tafluprost, an ophthalmic solution with a strength of 0.0045 mg per 0.3 mL, labeled by Micro Labs Limited. The diagram shows the molecular arrangement of tafluprost's atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.